Загрузка...
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
BACKGROUND: Cardiomyopathy is a leading cause of mortality among Duchenne muscular dystrophy patients and lacks effective therapies. Phosphodiesterase type 5 is implicated in dystrophic pathology, and the phosphodiesterase type 5 inhibitor tadalafil has recently been studied in a clinical trial for...
Сохранить в:
| Опубликовано в: : | J Am Heart Assoc |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5015305/ https://ncbi.nlm.nih.gov/pubmed/27506543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003911 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|